Defense Biotechnology Strategy Act

The Defense Biotechnology Strategy Act would direct the Secretary of Defense to create a formal plan to address the national security implications of emerging biotechnologies. The proposed strategy aims to ensure the United States remains competitive in fields like synthetic biology and genomic engineering, particularly in response to rapid advancements by global competitors. It would require the Department of Defense to outline how it will expand domestic biomanufacturing facilities, update military specifications to include bio-based products, and secure supply chains for critical biological materials.

If enacted, the bill would also focus on integrating biotechnology into military operations through wargaming and specialized workforce training programs. It proposes establishing a new management office to oversee these efforts and encourages deeper coordination with NATO allies to share research and streamline the purchase of biotechnology products. For everyday citizens, the bill represents an effort to bolster national security and economic competitiveness by fostering a domestic industry capable of producing advanced medicines, materials, and sensors using biological processes.